Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Helme

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Neurology and Therapy|February 27, 2026
The Use of Patient-Reported Outcome Measures in Developmental Age: A Complementary Tool for Pediatric Multiple Sclerosis PrognosisPaola Zaratin, Maria Pia Amato, Giampaolo Brichetto, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 23, 2025
Worldwide epidemiology of paediatric multiple sclerosis: data from the Multiple Sclerosis International Federation Atlas of MS, third editionGrace Gombolay, Laura Johnson, Rachel King, et al.
Multiple Sclerosis and Related Disorders|August 31, 2023
Barriers to accessing multiple sclerosis disease-modifying therapies in the Middle East and North Africa region: A regional survey-based studyMaya Zeineddine, Amal Al-Hajje, Pascale Salameh, et al.
Frontiers in Immunology|March 4, 2025
Artificial intelligence and science of patient input: a perspective from people with multiple sclerosisAnne Helme, Dipak Kalra, Giampaolo Brichetto, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2021
Ethical use of off-label disease-modifying therapies for multiple sclerosisJoanna Laurson-Doube, Nick Rijke, Anne Helme, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 31, 2024
The first global landscape analysis of multiple sclerosis research fundingBruce Bebo, Tim Coetzee, Emma Gray, et al.
Neurology|June 15, 2023
Global Barriers to the Diagnosis of Multiple Sclerosis: Data From the Multiple Sclerosis International Federation Atlas of MS, Third EditionAndrew J Solomon, Ruth Ann Marrie, Shanthi Viswanathan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 11, 2020
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third editionClare Walton, Rachel King, Lindsay Rechtman, et al.
Multiple Sclerosis and Related Disorders|June 27, 2025
Brain health - time matters: multiple sclerosis, neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and related conditions. 2024 reportHelmut Butzkueven, Sofia Arkelsten, Giancarlo Comi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 23, 2023
Introducing a core dataset for real-world data in multiple sclerosis registries and cohorts: Recommendations from a global task forceTina Parciak, Lotte Geys, Anne Helme, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Neurology and Therapy|February 27, 2026
The Use of Patient-Reported Outcome Measures in Developmental Age: A Complementary Tool for Pediatric Multiple Sclerosis PrognosisPaola Zaratin, Maria Pia Amato, Giampaolo Brichetto, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 23, 2025
Worldwide epidemiology of paediatric multiple sclerosis: data from the Multiple Sclerosis International Federation Atlas of MS, third editionGrace Gombolay, Laura Johnson, Rachel King, et al.
Multiple Sclerosis and Related Disorders|August 31, 2023
Barriers to accessing multiple sclerosis disease-modifying therapies in the Middle East and North Africa region: A regional survey-based studyMaya Zeineddine, Amal Al-Hajje, Pascale Salameh, et al.
Frontiers in Immunology|March 4, 2025
Artificial intelligence and science of patient input: a perspective from people with multiple sclerosisAnne Helme, Dipak Kalra, Giampaolo Brichetto, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2021
Ethical use of off-label disease-modifying therapies for multiple sclerosisJoanna Laurson-Doube, Nick Rijke, Anne Helme, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 31, 2024
The first global landscape analysis of multiple sclerosis research fundingBruce Bebo, Tim Coetzee, Emma Gray, et al.
Neurology|June 15, 2023
Global Barriers to the Diagnosis of Multiple Sclerosis: Data From the Multiple Sclerosis International Federation Atlas of MS, Third EditionAndrew J Solomon, Ruth Ann Marrie, Shanthi Viswanathan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 11, 2020
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third editionClare Walton, Rachel King, Lindsay Rechtman, et al.
Multiple Sclerosis and Related Disorders|June 27, 2025
Brain health - time matters: multiple sclerosis, neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and related conditions. 2024 reportHelmut Butzkueven, Sofia Arkelsten, Giancarlo Comi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 23, 2023
Introducing a core dataset for real-world data in multiple sclerosis registries and cohorts: Recommendations from a global task forceTina Parciak, Lotte Geys, Anne Helme, et al.
Pageof 2